# Vilazodone for the Treatment of Posttraumatic Stress Disorder

> **NCT01715519** · PHASE4 · COMPLETED · sponsor: **Southern California Institute for Research and Education** · enrollment: 59 (actual)

## Conditions studied

- PTSD
- Depression

## Interventions

- **DRUG:** Treatment (Viibryd)

## Key facts

- **NCT ID:** NCT01715519
- **Lead sponsor:** Southern California Institute for Research and Education
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715519, "Vilazodone for the Treatment of Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01715519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*